e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Mereo BioPharma Group plc - American Depositary Shares
(NQ:
MREO
)
0.5104
+0.0937 (+22.49%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mereo BioPharma Group plc - American Depositary Shares
< Previous
1
2
3
4
5
6
Next >
Mereo BioPharma to Present at the Jefferies Healthcare Conference
May 31, 2023
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Phase 2 Data from “ASTRAEUS” Trial of Mereo BioPharma’s Alvelestat in Alpha-1 Antitrypsin Deficiency-associated Lung Disease Presented at the 2023 American Thoracic Society International Conference
May 23, 2023
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Mereo BioPharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
May 08, 2023
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Mereo BioPharma Announces Listing Transfer to Nasdaq Capital Market
May 05, 2023
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Mereo BioPharma to Participate in Fireside Chat at the 22nd Annual Needham Healthcare Conference
April 13, 2023
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Mereo BioPharma Reports Full Year 2022 Financial Results and Recent Highlights
March 28, 2023
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Mereo BioPharma Provides Regulatory Updates on Alvelestat for the Treatment of Alpha-1-Antitrypsin Deficiency-Associated Lung Disease
March 21, 2023
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Why Blue Apron Shares Are Trading Lower By 12%; Here Are 20 Stocks Moving Premarket
↗
February 13, 2023
Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares rose 52.5% to $0.7050 in pre-market trading after jumping over 72% on Friday.
Via
Benzinga
Mereo BioPharma to Participate in Fireside Chat at the SVB Securities Global Biopharma Conference
February 08, 2023
From
Mereo BioPharma Group plc
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
↗
January 02, 2023
Via
Benzinga
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session
↗
December 30, 2022
Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
December 27, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
December 22, 2022
Via
Benzinga
Why Venus Concept Shares Are Trading Higher By Over 63%? Here Are 58 Stocks Moving In Wednesday's Mid-Day Session
↗
December 21, 2022
Gainers Sintx Technologies, Inc. (NASDAQ: SINT) shares climbed 81.4% to $13.55 after the company was awarded Phase I contract for $150,000 from the Missile Defense Agency for electrochemical...
Via
Benzinga
Mereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare Conference
November 08, 2022
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Mereo BioPharma Received Notification of Nasdaq Minimum Bid Price Deficiency
November 02, 2022
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Mereo BioPharma Reaches Cooperation Agreement with Rubric Capital Management
October 28, 2022
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Mereo BioPharma to Host Alvelestat R&D Update Call on October 31, 2022
October 24, 2022
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Mereo BioPharma Files Shareholder Circular for Upcoming General Meeting
October 21, 2022
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Rubric Capital Management Comments on Mereo BioPharma Updated Operating Plan
October 18, 2022
From
Rubric Capital Management LP
Via
Business Wire
Mereo BioPharma Announces Updated Operating Plan to Maximize Shareholder Value
October 18, 2022
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Mereo BioPharma Receives FDA Fast Track Designation for Alvelestat for Treatment of Alpha-1 Antitrypsin Deficiency (AATD)-associated Lung Disease
October 17, 2022
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Mereo BioPharma Confirms Receipt of a Valid Notice Requiring it to Convene a General Meeting of Shareholders
October 03, 2022
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Rubric Capital Management Increases Slate of Proposed Mereo BioPharma Director Nominees to Five
October 03, 2022
From
Rubric Capital Management LP
Via
Business Wire
Rubric Capital Management Issues Open Letter to Mereo BioPharma Shareholders
September 14, 2022
From
Rubric Capital Management LP
Via
Business Wire
Alibaba, Zoom Video And 76 Biggest Movers From Yesterday
↗
July 12, 2022
Gainers Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention of the stock on social media.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
July 05, 2022
Via
Benzinga
This Technology Stock is Down By Over 11%: Here's 26 Stocks Moving Premarket
↗
July 05, 2022
Gainers FedNat Holding Company (NASDAQ: FNHC) rose 32.3% to $0.4764 in pre-market trading after jumping over 16% on Friday.
Via
Benzinga
Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday
↗
July 05, 2022
Gainers Omeros Corporation (NASDAQ: OMER) jumped 68.7% to close at $4.64. Clovis Oncology, Inc. (NASDAQ: CLVS) gained 58.3% to settle at $2.85 on Friday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
July 01, 2022
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.